Drug Shortage Report for AURO-VALSARTAN HCT
Report ID | 134549 |
Drug Identification Number | 02408155 |
Brand name | AURO-VALSARTAN HCT |
Common or Proper name | Valsartan HCT |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | VALSARTAN HYDROCHLOROTHIAZIDE |
Strength(s) | 320MG 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30's |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-02-18 |
Estimated end date | Unknown |
Actual end date | 2023-11-10 |
Shortage status | Resolved |
Updated date | 2023-11-11 |
Company comments | Replaceable with Auro-Valsartan HCT 320mg/25mg Tab 100 Btl |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-02-22 | English | Compare |
v2 | 2021-02-22 | French | Compare |
v3 | 2021-04-12 | English | Compare |
v4 | 2021-04-12 | French | Compare |
v5 | 2023-11-10 | English | Compare |
v6 | 2023-11-10 | French | Compare |
v7 | 2023-11-11 | English | Compare |
Showing 1 to 7 of 7